Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
4 June 2013 -- Following today’s Parliamentary debate on science and research in the UK, led by Dr Julian Huppert MP, Steve Bates, BioIndustry Association (BIA) Chief Executive Officer, said:
“The BioIndustry would like to applaud Julian Huppert for raising this important topic in Parliament. I was delighted to hear his support for innovation in general and the Biomedical Catalyst, which has been well received in our sector and has leveraged in significant amounts of additional private funding for companies, in particular.
“I also welcome Dr Huppert’s positive comments on the BIA’s Citizens’ Innovation Funds (CIFs) proposal. CIFs are a proposed tax-advantaged investment scheme providing an opportunity to leverage the patriotic potential of the British public to invest in innovative UK companies and provide additional private investment to the new products and technologies of tomorrow.”
For further information, please contact Robert Winder, Head of Communications, rwinder@bioindustry.org, 020 7630 2191; mobile 07825 942 934.
The Westminster Hall debate on support for science and research was secured by Dr Julian Huppert and held on Tuesday 4 June, 14.30 - 16.00. The debate can be watched on Parliament TV: http://www.parliamentlive.tv/Main/Player.aspx?meetingId=13190
Biomedical Catalyst
BIA report on the Biomedical Catalyst: http://bit.ly/BIA_bmc
Citizens’ Innovation Funds
BIA proposal for Citizens’ Innovation Funds: http://bit.ly/BIACIF
BioIndustry Association
Founded over 20 years ago at the infancy of biotechnology, the BioIndustry Association (BIA) is the trade association for innovative enterprises involved in UK bioscience. Members include emerging and more established bioscience companies; pharmaceutical companies; academic, research and philanthropic organisations; and service providers to the bioscience sector. The BIA represents the interests of its members to a broad section of stakeholders, from government and regulators to patient groups and the media. Our goal is to secure the UK’s position as a global hub and as the best location for innovative research and commercialisation, enabling our world-leading research base to deliver healthcare solutions that can truly make a difference to people’s lives. For further information, please go to www.bioindustry.org
Help employers find you! Check out all the jobs and post your resume.
